ARCHIVES

Also Bristol-Myers Squibb Under Federal Investigation Over Plavix Deal.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

NIH Objects To Big Response On Immunology RFPs, But NCI Will Continue Wide Distribution

November 1, 1974

NCI Grant Funding Up $74 Million; Centers, Groups also Receive Funding Boost

March 8, 1996

Bristol-Lyers Squibb, Axion In Joint Venture To Sell Oncology Drugs to Office-Base Practices

September 3, 1993

Novel Treatment Modalities Tested Against Bladder Cancer

May 27, 2005

NCCS Networker Volume 10 Issue 1, Spring 1996

April 13, 1996